Experts
Anne Wojcicki
Co-Founder, 23andMe
Recent Activity
Big Think Interview with Anne Wojcicki
A conversation with the Co-founder and President of 23andMe. … Watch
October 27, 2009 | In Health & Medicine
Anne's background is in healthcare investing, focused primarily on biotechnology companies. Anne left the investing world with the hope that she could have a positive impact on research and medicine through 23andMe. From her vantage point, Anne saw a need for creating a way to generate more information - especially more personalized information - so that commercial and academic researchers could better understand and develop new drugs and diagnostics. By encouraging individuals to access and learn about their own genetic information, 23andMe will create a common, standardized resource that has the potential to accelerate drug discovery and bring personalized medicine to the public. Anne graduated from Yale University with a B.S. in biology.
